Dr. Papaliodis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-573-4169
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 2001 - 2002
- Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2001
- University of Texas Southwestern Medical CenterResidency, Ophthalmology, 1996 - 1999
- Massachusetts General HospitalInternship, Internal Medicine, 1995 - 1996
- University of Texas Southwestern Medical SchoolClass of 1995
Certifications & Licensure
- MA State Medical License 2000 - 2025
- TX State Medical License 1998 - 2007
- RI State Medical License 2003 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- PEMF: an Adjunct Therapy for Anterior Uveitis Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- State-of-the-Art Review: Ocular Infections.Miriam B Barshak, Marlene L Durand, Akash Gupta, Amir M Mohareb, Thomas H Dohlman
Clinical Infectious Diseases. 2024-11-22 - Executive Summary: State-of-the-Art Review: Ocular Infections.Miriam B Barshak, Marlene L Durand, Akash Gupta, Amir M Mohareb, Thomas H Dohlman
Clinical Infectious Diseases. 2024-11-22 - Malignancy Risk Associated With the Use of Systemic Immunomodulatory Therapy in the Management of Noninfectious Uveitis.George N Papaliodis, Yinxi Yu, Daniel A Brill, Lucia Sobrin, Brian VanderBeek
American Journal of Ophthalmology. 2024-09-01
Other
- Eales' diseasePapaliodis GN
http://www.uptodate.com/contents/eales-disease
UpToDate, Wolters Kluwer Health - 2012-07-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: